Latest News about VRTX
Recent news which mentions VRTX
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
From Benzinga
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
December 13, 2023
From Benzinga
Vertex's Non-Opioid Diabetes Associated Nerve Pain Treatment Candidate Aces Mid-Stage Trial
December 13, 2023
Tickers
VRTX
From Benzinga
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
December 13, 2023
From InvestorPlace
From MarketWatch
1 Biotech Stock That Could Be the Next Amgen
December 13, 2023
From Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
December 13, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
Why CRISPR Stock Keeps Falling
December 11, 2023
From Motley Fool
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
December 10, 2023
From Motley Fool
From Motley Fool
Forget the "Magnificent Seven": Buy This Stock Instead
December 09, 2023
Tickers
VRTX
From Motley Fool
From Motley Fool
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
From Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
From MarketWatch
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
December 08, 2023
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
December 07, 2023
From Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
December 07, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
December 05, 2023
Tickers
VRTX
From Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
From Motley Fool
Looking Into Vertex Pharmaceuticals's Recent Short Interest
December 04, 2023
Tickers
VRTX
From Benzinga
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
From Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
December 04, 2023
From Motley Fool
3 No-Brainer Growth Stocks to Buy in December
December 03, 2023
From Motley Fool
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
December 03, 2023
From Motley Fool